Paper8996540
Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature.
Fazeny B and 9 others. J Cancer Res Clin Oncol, 1997. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature. Papers, record 8996540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8996540
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Hormonal | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Pancreatic Neoplasms | Major topic |
| Aged | |
| Female | |
| Goserelin | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Octreotide | |
| Pilot Projects |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6141560 | Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6141560 | PubMed |
| 2 | 1346097 | Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study. | Cancer | 1992 | https://conductscience.org/library/papers/1346097 | PubMed |
| 3 | 1977468 | Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects. | Br J Cancer | 1990 | https://conductscience.org/library/papers/1977468 | PubMed |
| 4 | 2573055 | Membrane receptors for peptides in experimental and human pancreatic cancers. | Pancreas | 1989 | https://conductscience.org/library/papers/2573055 | PubMed |
| 5 | 2300842 | Sandostatin-induced thrombocytopenia. | South Med J | 1990 | https://conductscience.org/library/papers/2300842 | PubMed |
| 6 | 7804972 | Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. | Cancer | 1995 | https://conductscience.org/library/papers/7804972 | PubMed |
| 7 | 8532003 | Octreotide. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8532003 | PubMed |
| 8 | 1513800 | Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin. | Pancreas | 1992 | https://conductscience.org/library/papers/1513800 | PubMed |
| 9 | 2871684 | Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. | Acta Endocrinol (Copenh) | 1986 | https://conductscience.org/library/papers/2871684 | PubMed |
| 10 | 2567204 | Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer. | Cancer Lett | 1989 | https://conductscience.org/library/papers/2567204 | PubMed |
| 11 | 7819058 | A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7819058 | PubMed |
| 12 | 3955505 | Androgen receptor in human normal and malignant pancreatic tissue and cell lines. | Cancer | 1986 | https://conductscience.org/library/papers/3955505 | PubMed |
| 13 | 7459811 | Reporting results of cancer treatment. | Cancer | 1981 | https://conductscience.org/library/papers/7459811 | PubMed |
| 14 | 7786820 | Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study. | Ann Oncol | 1995 | https://conductscience.org/library/papers/7786820 | PubMed |
| 15 | 6128648 | SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. | Life Sci | 1982 | https://conductscience.org/library/papers/6128648 | PubMed |
| 16 | 6791734 | Oestrogen receptor proteins in malignant and fetal pancreas. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6791734 | PubMed |
| 17 | 2659684 | Androgen influence on exocrine pancreatic cancer. | Int J Pancreatol | 1989 | https://conductscience.org/library/papers/2659684 | PubMed |
| 18 | 8373420 | Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. | Biochem Biophys Res Commun | 1993 | https://conductscience.org/library/papers/8373420 | PubMed |
| 19 | 8204534 | Multimodality treatment of locally advanced pancreatic cancer. | Ann Oncol | 1994 | https://conductscience.org/library/papers/8204534 | PubMed |
| 20 | 8302789 | Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer. | Pancreas | 1993 | https://conductscience.org/library/papers/8302789 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31451931 | Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours. | J Cancer Res Clin Oncol | 2019 | https://conductscience.org/library/papers/31451931 | PubMed |
| 23667314 | A review of the use of somatostatin analogs in oncology. | Onco Targets Ther | 2013 | https://conductscience.org/library/papers/23667314 | PubMed |
| 22529684 | Adjuvant and neoadjuvant treatment in pancreatic cancer. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22529684 | PubMed |
| 19521786 | Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster. | Clin Exp Metastasis | 2009 | https://conductscience.org/library/papers/19521786 | PubMed |
| 14688834 | Pancreatic cancer - a continuing challenge in oncology. | Pathol Oncol Res | 2003 | https://conductscience.org/library/papers/14688834 | PubMed |
| 10852640 | Pancreatic cancer: a review of emerging therapies. | Drugs | 2000 | https://conductscience.org/library/papers/10852640 | PubMed |
| 9951952 | Practical recommendations for the management of adenocarcinoma of the pancreas. | Drugs | 1999 | https://conductscience.org/library/papers/9951952 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8996540
GET https://conductscience.org/api/papers/v1/8996540/references?page=2